Cargando…
Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation pathway implicated in the pathogenesis of cancer and neurodegenerative diseases. However, the mechanisms that regulate CMA are not fully understood. Here, using unbiased drug screening approaches, we discover Metformin,...
Autores principales: | Xu, Xiaoyan, Sun, Yaqin, Cen, Xufeng, Shan, Bing, Zhao, Qingwei, Xie, Tingxue, Wang, Zhe, Hou, Tingjun, Xue, Yu, Zhang, Mengmeng, Peng, Di, Sun, Qiming, Yi, Cong, Najafov, Ayaz, Xia, Hongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464644/ https://www.ncbi.nlm.nih.gov/pubmed/34291435 http://dx.doi.org/10.1007/s13238-021-00858-3 |
Ejemplares similares
-
Correction to: Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model
por: Xu, Xiaoyan, et al.
Publicado: (2021) -
Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer’s disease mouse model
por: Cen, Xufeng, et al.
Publicado: (2020) -
ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
por: Wu, Youqian, et al.
Publicado: (2021) -
Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease
por: Cen, Xufeng, et al.
Publicado: (2020) -
CrossCheck: an open-source web tool for high-throughput screen data analysis
por: Najafov, Jamil, et al.
Publicado: (2017)